Literature DB >> 2871113

Antibody-induced caps in Entamoeba histolytica: isolation and electrophoretic analysis.

J Calderón, E E Avila.   

Abstract

Polyspecific antibodies bound to the cell surface of Entamoeba histolytica are polarized toward the uroid region and spontaneously released by the amoeba as supramolecular aggregate or cap. We purified these exfoliated structures and analyzed them by electron microscopy and sodium dodecyl sulfate electrophoresis. Isolated caps were mainly composed of membranes and contained five major [35S]methionine-labeled bands; many more bands appeared (together with immunoglobulins) after silver staining. Surface immunoprecipitates contained about twelve major [35S]methionine-labeled polypeptides, five of which had molecular weights similar to those of radiolabeled polypeptides in the cap. Some proteins in the caps had the same electrophoretic migration pattern as that from iodinated cell-surface proteins and polypeptides from isolated plasma membranes. Results suggest that only half of the surface-immunoprecipitated antigens are enriched in the cap.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871113     DOI: 10.1093/infdis/153.5.927

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Differences in cap formation between invasive Entamoeba histolytica and non-invasive Entamoeba dispar.

Authors:  Bibiana Chávez-Munguía; Patricia Talamás-Rohana; Guadalupe Castañón; Lizbeth Salazar-Villatoro; Verónica Hernández-Ramírez; Adolfo Martínez-Palomo
Journal:  Parasitol Res       Date:  2012-01-26       Impact factor: 2.289

2.  Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells.

Authors:  H W Favoreel; H J Nauwynck; P Van Oostveldt; T C Mettenleiter; M B Pensaert
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Downregulation of an Entamoeba histolytica rhomboid protease reveals roles in regulating parasite adhesion and phagocytosis.

Authors:  Leigh A Baxt; Elena Rastew; Rivka Bracha; David Mirelman; Upinder Singh
Journal:  Eukaryot Cell       Date:  2010-06-25

4.  cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica.

Authors:  B E Torian; B M Flores; V L Stroeher; F S Hagen; W E Stamm
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica.

Authors:  P Arhets; P Gounon; P Sansonetti; N Guillén
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera.

Authors:  W A Petri; M P Joyce; J Broman; R D Smith; C F Murphy; J I Ravdin
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

7.  Localization of myosin heavy chain A in the human pathogen Entamoeba histolytica.

Authors:  Z Rahim; A Raymond-Denise; P Sansonetti; N Guillen
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  Longitudinal evaluation of enteric protozoa in Haitian children by stool exam and multiplex serologic assay.

Authors:  Delynn M Moss; Jeffrey W Priest; Kathy Hamlin; Gordana Derado; Joel Herbein; William A Petri; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2014-03-03       Impact factor: 2.345

9.  The 96-kilodalton antigen as an integral membrane protein in pathogenic Entamoeba histolytica: potential differences in pathogenic and nonpathogenic isolates.

Authors:  B E Torian; S L Reed; B M Flores; C M Creely; J E Coward; K Vial; W E Stamm
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

10.  A proteomic and cellular analysis of uropods in the pathogen Entamoeba histolytica.

Authors:  Jacques Marquay Markiewicz; Sylvie Syan; Chung-Chau Hon; Christian Weber; Daniela Faust; Nancy Guillen
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.